Papers

7

Total Citations

171

H-Index

6

About

Eugene Yu is a clinician-researcher whose work sits at the intersection of head and neck oncology, advanced surgical techniques, and precision radiotherapy. His most cited contribution — a 2010 paper on stereotactic body radiotherapy for spinal metastases (73 citations) — established foundational technique-based guidance that continues to inform radiation oncology practice. More recently, Yu has emerged as a leading voice in transoral robotic surgery (TORS), exploring its role in oropharyngeal squamous cell carcinoma (OPSCC), unknown primary cancers of the neck, and image-guided surgical innovation. His 2019 work examining occult nodal disease in OPSCC (32 citations) addressed a critical knowledge gap created by the rise of HPV as a dominant causative agent, while companion studies investigated how preoperative imaging can optimize patient selection for TORS procedures. Notably, Yu co-led the FIND trial, a pioneering phase 2 study integrating TORS with histopathological localization to enable targeted radiotherapy deintensification — reducing treatment burden for patients with unknown primary head and neck cancers. Across his body of work, Yu consistently pursues a unifying goal: refining oncologic precision while preserving patients' quality of life.

Research Focus

Key Achievements

6
H-Index
7
Papers
171
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Technique for stereotactic body radiotherapy for spinal metastases
73 citations · 2010
📈 Most Prolific Year: 2019 (4 Papers)
🤝 Key Collaborators: 53
🏛 Institutions: University of Toronto, Mount Sinai Hospital, University Health Network, Princess Margaret Cancer Centre

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago